13/02/2019
Greetings from RAAJ GPRAC PVT. LTD.
We are pleased to invite you for our next important seminar on Data integrity, CSV. Kindly book your seats at the earliest to avail early bird discounts.
2 Days Seminar on Computer System Validation [CSV] as per 21CFRpart11, EU Annex-11, PICs, GAMP-5, DATE- 15-16th MARCH 2019
Data Integrity a Top Concern for Pharma, Biotech Manufacturers, CRO, BPO, IT Etc.
In the past few years, several FDA warning letters (483s) have been issued for data integrity deficiencies in the pharmaceutical industry. In 2016, more than 50 percent of MHRA warning letters involved data integrity lapses for computerized systems compared to the previous year. Inspectors are actively trained in data integrity requirements, and strongly enforce them for falsified batch records or discharging of raw data. Understanding recent standards, guides, and regulations pertaining to data integrity is essential to becoming compliant. Relevant documents include 21 CFR Part 11, MHRA: GxP, EU GMP Annex 1, the FDA Data Integrity and Compliance with cGMP, and the WHO Good Data and Record Management Practices. Inherent to data integrity compliance is the goal of increasing product quality, regulator confidence, brand reputation, and process control, while reducing product defects and costs. This applies to multiple areas of the pharmaceutical industry, including manufacturers of finished drug products for clinical trials, bioequivalence studies and commercial distribution, laboratories, contract manufacturing, suppliers, etc.
Data integrity is an old concept made essential in today’s digital age, and means data that is accurate, complete, and repeatable, which in turn ensures the product’s quality and public safety. In recent years, infractions relating to data integrity have been noted in several Food and Drug Administration (FDA) warning letters. The importance of record-keeping in drug manufacturing can be seen as far back as 1938, when the Federal Food, Drug, and Cosmetic (FDC) Act required the safety of new drugs be documented before being sold to the public, with similar regulations instigated in Europe and Japan throughout the 20th century.1
Production systems have large, inherent operational risks and are difficult to validate. Instead of exclusively reacting to public health disasters, preventative measures — such as the requirement for proof of claims — are taken to lower their likelihood and instill confidence in manufacturers.
We at RAAJ GPRAC PVT. LTD have given some serious thought to the issues and challenges pertinent to the CSV and are organizing a SEMINAR on “CSV as per 21CFRpart11, EU-Annexx11, PICs, GAMP-5”. This seminar will be held from 14th & 15th March 2019 at RAAJ GPRAC TRAINING CENTRE. MUMBAI-THANE.
LEARNING OBJECTIVES:
-DATA INTEGRITY ISSUES
-RISK ASSESSMENTS
-CSV AS PER 21 CFR PART 11, EU-ANNEX-11,
-GAMP-5 CATEGORIES & V-MODEL
-CURRENT ISSUES & INDUSTRY TREND
-DOCUMENTATION REQUIRED FOR COMPLIANCE
-SOP, URS, FRS, BCP etc.
-CASE STUDIES
-Brainstrorming & Many more
FEES 15000/- P.P for 2 days [INCLUDES TRAINING KIT, 2 days Lunch, Snacks, Tea, Certificate]
5% Discount for 3 participants
10% Discounts for 5 & more participants.
Thanks and looking forward to your presence
Best regards,
Rajashri ojha
Founder & MD,
2 Todays workshop in Computer system validation as per 21CFR Part 11, Annex-11 and GAMP-5